TGF-β also remodels the tumor microenvironment by activating cancer-associated fibroblasts, promoting ECM deposition, secreting pro-tumorigenic cytokines, and enhancing invasion and angiogenesis. The gene discussed is TGFB1; the disease is neoplasm.